Physician Interpretations and Textbook Definitions of Blinding Terminology in Randomized Controlled Trials, JAMA, vol.285, issue.15, pp.2000-2003, 2001. ,
DOI : 10.1001/jama.285.15.2000
The Landscape and Lexicon of Blinding in Randomized Trials, Annals of Internal Medicine, vol.136, issue.3, pp.254-259, 2002. ,
DOI : 10.7326/0003-4819-136-3-200202050-00022
Blinding in randomised trials: hiding who got what, The Lancet, vol.359, issue.9307, pp.696-700, 2002. ,
DOI : 10.1016/S0140-6736(02)07816-9
Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials, JAMA: The Journal of the American Medical Association, vol.273, issue.5, pp.408-412, 1995. ,
DOI : 10.1001/jama.273.5.408
Blinding and exclusions after allocation in randomised controlled trials: survey of published parallel group trials in obstetrics and gynaecology, BMJ, vol.312, issue.7033, pp.742-744, 1996. ,
DOI : 10.1136/bmj.312.7033.742
Bias in Clinical Intervention Research, American Journal of Epidemiology, vol.163, issue.6, pp.493-501, 2006. ,
DOI : 10.1093/aje/kwj069
Is the Placebo Powerless? An Analysis of Clinical Trials Comparing Placebo With no Treatment, Obstetrical and Gynecological Survey, vol.56, issue.10, pp.1594-1602, 2001. ,
DOI : 10.1097/00006254-200110000-00021
What are the main methodological problems in the estimation of placebo effects?, Journal of Clinical Epidemiology, vol.55, issue.5, pp.430-435, 2002. ,
DOI : 10.1016/S0895-4356(01)00496-6
The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial, Neurology, vol.44, issue.1, pp.16-20, 1994. ,
DOI : 10.1212/WNL.44.1.16
In randomized controlled trials, should subjects in both placebo and drug groups be expected to guess that they are taking drug 50% of the time?, Medical Hypotheses, vol.59, issue.3, pp.227-232, 2002. ,
DOI : 10.1016/S0306-9877(02)00205-0
Lessons Learned from Attempts To Establish the Blind in Placebo-Controlled Trials of Zinc for the Common Cold, Annals of Internal Medicine, vol.133, issue.4, pp.302-303, 2000. ,
DOI : 10.7326/0003-4819-133-4-200008150-00016
Journal citation reports Available: http:// isiwebofknowledge.com. Accessed, 2003. ,
Blinding was judged more difficult to achieve and maintain in nonpharmacologic than pharmacologic trials, Journal of Clinical Epidemiology, vol.57, issue.6, pp.543-550, 2004. ,
DOI : 10.1016/j.jclinepi.2003.12.010
Testing the success of blinding in randomised clinical trials [abstract]. 12th Cochrane Colloquium: Bridging the Gaps, pp.138-139, 2004. ,
A review of blinding in randomized controlled trials found results inconsistent and questionable, Journal of Clinical Epidemiology, vol.58, issue.12, pp.1220-1226, 2005. ,
DOI : 10.1016/j.jclinepi.2005.04.006
Turning a blind eye: the success of blinding reported in a random sample of randomised, placebo controlled trials, BMJ, vol.328, issue.7437, p.432, 2004. ,
DOI : 10.1136/bmj.37952.631667.EE
Co-Administration of Nitric Oxide-Aspirin (NCX-4016) and Aspirin Prevents Platelet and Monocyte Activation and Protects Against Gastric Damage Induced by Aspirin in Humans, Journal of the American College of Cardiology, vol.44, issue.3, pp.635-641, 2004. ,
DOI : 10.1016/j.jacc.2004.03.079
Topical 4% Amethocaine Gel Reduces the Pain of Subcutaneous Measles-Mumps-Rubella Vaccination, PEDIATRICS, vol.114, issue.6, pp.720-724, 2004. ,
DOI : 10.1542/peds.2004-0722
Splinting vs Surgery in the Treatment of Carpal Tunnel Syndrome, JAMA, vol.288, issue.10, pp.1245-1251, 2002. ,
DOI : 10.1001/jama.288.10.1245
Comparison of Ximelagatran with Warfarin for the Prevention of Venous Thromboembolism after Total Knee Replacement, New England Journal of Medicine, vol.349, issue.18, pp.1703-1712, 2003. ,
DOI : 10.1056/NEJMoa035162
Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial, Annals of the Rheumatic Diseases, vol.64, issue.8, pp.1227-1236, 2005. ,
DOI : 10.1136/ard.2004.032268
Stimulant and relaxant drugs combined with stimulant and relaxant information: a study of active placebo, Psychopharmacology, vol.8, issue.3-4, pp.426-434, 2004. ,
DOI : 10.1007/s00213-004-1886-7
Analgesic Effects of Intravenous Lidocaine and Morphine on Postamputation Pain, Anesthesiology, vol.96, issue.4, pp.841-848, 2002. ,
DOI : 10.1097/00000542-200204000-00010
Randomised double-blind active-placebo-controlled crossover trial of intravenous fentanyl in neuropathic pain, The Lancet, vol.349, issue.9054, pp.753-758, 1997. ,
DOI : 10.1016/S0140-6736(96)09024-1
Randomized Controlled Trial of Syn-Ergel and an Active Placebo in the Treatment of Heartburn of Pregnancy, Journal of International Medical Research, vol.52, issue.2, pp.147-151, 1978. ,
DOI : 10.1177/030006057800600215
The Ethics of Placebo-controlled Trials: A Comparison of Inert and Active Placebo Controls, World Journal of Surgery, vol.20, issue.3 Suppl, pp.610-614, 2005. ,
DOI : 10.1007/s00268-005-7621-7
Dose dependence and time course of the immunologic response to administration of standardized cat allergen extract, Journal of Allergy and Clinical Immunology, vol.114, issue.6, pp.1339-1344, 2004. ,
DOI : 10.1016/j.jaci.2004.08.049
Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?, The Lancet, vol.352, issue.9128, pp.609-613, 1998. ,
DOI : 10.1016/S0140-6736(98)01085-X
The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration, Annals of Internal Medicine, vol.134, issue.8, pp.663-694, 2001. ,
DOI : 10.7326/0003-4819-134-8-200104170-00012
Duration of Symptoms and Plasma Cytokine Levels in Patients with the Common Cold Treated with Zinc Acetate, Annals of Internal Medicine, vol.133, issue.4, pp.245-252, 2000. ,
DOI : 10.7326/0003-4819-133-4-200008150-00006
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?, Controlled Clinical Trials, vol.17, issue.1, pp.1-12, 1996. ,
DOI : 10.1016/0197-2456(95)00134-4
The art of quality assessment of RCTs included in systematic reviews, Journal of Clinical Epidemiology, vol.54, issue.7, pp.651-654, 2001. ,
DOI : 10.1016/S0895-4356(00)00360-7
The Delphi List, Journal of Clinical Epidemiology, vol.51, issue.12, pp.1235-1241, 1998. ,
DOI : 10.1016/S0895-4356(98)00131-0
A checklist to evaluate a report of a nonpharmacological trial (CLEAR NPT) was developed using consensus, Journal of Clinical Epidemiology, vol.58, issue.12, pp.1233-1240, 2005. ,
DOI : 10.1016/j.jclinepi.2005.05.004
Comparison of descriptions of allocation concealment in trial protocols and the published reports: cohort study, BMJ, vol.330, issue.7499, p.1049, 2005. ,
DOI : 10.1136/bmj.38414.422650.8F